Company intelligence / Profile preview

Tepsivo

Ownership: Private
Development stage: Commercial

Overview

Tepsivo has developed and commercialized the world’s first fully integrated end-to-end digital pharmacovigilance system—OnePV—which automates and centralizes PV activities across more than 150 countries. The solution is used by over 50 pharmaceutical and biotech companies to streamline safety monitoring, regulatory compliance, and reporting. The company’s approach combines expert human oversight with advanced AI-driven automation.

Modalities: Not applicable
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Clinigen Group plc (strategic partnership; Clinigen acquired a minority stake in January 2025)

Beyond the preview

Go deeper on Tepsivo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tepsivo.

Explore the full profile